| Year |
Citation |
Score |
| 2024 |
Aroni S, Sagheddu C, Pistis M, Muntoni AL. Functional Adaptation in the Brain Habenulo-Mesencephalic Pathway During Cannabinoid Withdrawal. Cells. 13. PMID 39513916 DOI: 10.3390/cells13211809 |
0.771 |
|
| 2023 |
Sagheddu C, Cancedda E, Bagheri F, Kalaba P, Muntoni AL, Lubec J, Lubec G, Sanna F, Pistis M. The atypical dopamine transporter inhibitor CE-158 enhances dopamine neurotransmission in the prefrontal cortex of male rats: a behavioral, electrophysiological and microdialysis study. The International Journal of Neuropsychopharmacology. PMID 37725477 DOI: 10.1093/ijnp/pyad056 |
0.674 |
|
| 2023 |
Sagheddu C, Devoto P, Aroni S, Saba P, Pistis M, Gessa GL. Combined α- and D-receptor blockade activates noradrenergic and dopaminergic neurons, but extracellular dopamine in the prefrontal cortex is determined by uptake and release from noradrenergic terminals. Frontiers in Pharmacology. 14: 1238115. PMID 37680715 DOI: 10.3389/fphar.2023.1238115 |
0.428 |
|
| 2023 |
Ferré S, Köfalvi A, Ciruela F, Justinova Z, Pistis M. Targeting corticostriatal transmission for the treatment of cannabinoid use disorder. Trends in Pharmacological Sciences. PMID 37331914 DOI: 10.1016/j.tips.2023.05.003 |
0.413 |
|
| 2023 |
Santoni M, Sagheddu C, Serra V, Mostallino R, Paola Castelli M, Pisano F, Scherma M, Fadda P, Muntoni AL, Zamberletti E, Rubino T, Melis M, Pistis M. Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring. Brain, Behavior, and Immunity. PMID 36746342 DOI: 10.1016/j.bbi.2023.02.002 |
0.777 |
|
| 2022 |
Murru E, Muntoni AL, Manca C, Aroni S, Pistis M, Banni S, Carta G. Profound Modification of Fatty Acid Profile and Endocannabinoid-Related Mediators in PPARα Agonist Fenofibrate-Treated Mice. International Journal of Molecular Sciences. 24. PMID 36614161 DOI: 10.3390/ijms24010709 |
0.607 |
|
| 2022 |
Kouhnavardi S, Ecevitoglu A, Dragačević V, Sanna F, Arias-Sandoval E, Kalaba P, Kirchhofer M, Lubec J, Niello M, Holy M, Zehl M, Pillwein M, Wackerlig J, Murau R, Mohrmann A, ... ... Pistis M, et al. A Novel and Selective Dopamine Transporter Inhibitor, -MK-26, Promotes Hippocampal Synaptic Plasticity and Restores Effort-Related Motivational Dysfunctions. Biomolecules. 12. PMID 35883437 DOI: 10.3390/biom12070881 |
0.351 |
|
| 2022 |
Santoni M, Frau R, Pistis M. Transgenerational Sex-dependent Disruption of Dopamine Function Induced by Maternal Immune Activation. Frontiers in Pharmacology. 13: 821498. PMID 35211019 DOI: 10.3389/fphar.2022.821498 |
0.395 |
|
| 2021 |
Sagheddu C, Melis M, Muntoni AL, Pistis M. Repurposing Peroxisome Proliferator-Activated Receptor Agonists in Neurological and Psychiatric Disorders. Pharmaceuticals (Basel, Switzerland). 14. PMID 34681249 DOI: 10.3390/ph14101025 |
0.722 |
|
| 2021 |
Congiu M, Micheli L, Santoni M, Sagheddu C, Muntoni AL, Makriyannis A, Malamas MS, Ghelardini C, Di Cesare Mannelli L, Pistis M. N-Acylethanolamine Acid Amidase Inhibition Potentiates Morphine Analgesia and Delays the Development of Tolerance. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 34553321 DOI: 10.1007/s13311-021-01116-4 |
0.645 |
|
| 2021 |
Lubec J, Kalaba P, Hussein AM, Feyissa DD, Kotob MH, Mahmmoud RR, Wieder O, Garon A, Sagheddu C, Ilic M, Dragačević V, Cybulska-Klosowicz A, Zehl M, Wackerlig J, Sartori SB, ... ... Pistis M, et al. Reinstatement of synaptic plasticity in the aging brain through specific dopamine transporter inhibition. Molecular Psychiatry. PMID 34244620 DOI: 10.1038/s41380-021-01214-x |
0.305 |
|
| 2021 |
Pintori N, Castelli MP, Miliano C, Simola N, Fadda P, Fattore L, Scherma M, Ennas MG, Mostallino R, Flore G, De Felice M, Sagheddu C, Pistis M, Di Chiara G, De Luca MA. REPEATED EXPOSURE TO JWH-018 INDUCES ADAPTIVE CHANGES IN THE MESOLIMBIC AND MESOCORTICAL DOPAMINE PATHWAYS, GLIAL CELLS ALTERATION AND BEHAVIOURAL CORRELATES. British Journal of Pharmacology. PMID 33837969 DOI: 10.1111/bph.15494 |
0.341 |
|
| 2020 |
Murru E, Carta G, Manca C, Sogos V, Pistis M, Melis M, Banni S. Conjugated Linoleic Acid and Brain Metabolism: A Possible Anti-Neuroinflammatory Role Mediated by PPARα Activation. Frontiers in Pharmacology. 11: 587140. PMID 33505308 DOI: 10.3389/fphar.2020.587140 |
0.448 |
|
| 2020 |
Sagheddu C, Torres LH, Marcourakis T, Pistis M. Endocannabinoid-Like Lipid Neuromodulators in the Regulation of Dopamine Signaling: Relevance for Drug Addiction. Frontiers in Synaptic Neuroscience. 12: 588660. PMID 33424577 DOI: 10.3389/fnsyn.2020.588660 |
0.369 |
|
| 2020 |
Devoto P, Sagheddu C, Santoni M, Flore G, Saba P, Pistis M, Gessa GL. Noradrenergic Source of Dopamine Assessed by Microdialysis in the Medial Prefrontal Cortex. Frontiers in Pharmacology. 11: 588160. PMID 33071798 DOI: 10.3389/fphar.2020.588160 |
0.439 |
|
| 2020 |
Sagheddu C, Pintori N, Kalaba P, Dragačević V, Piras G, Lubec J, Simola N, De Luca MA, Lubec G, Pistis M. Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer ()-CE-123 on Mesocorticolimbic Dopamine System. Biomolecules. 10. PMID 32443397 DOI: 10.3390/biom10050779 |
0.369 |
|
| 2019 |
Lecca S, Luchicchi A, Scherma M, Fadda P, Muntoni AL, Pistis M. Δ-Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation. Frontiers in Behavioral Neuroscience. 13: 202. PMID 31551729 DOI: 10.3389/Fnbeh.2019.00202 |
0.825 |
|
| 2019 |
Rotolo RA, Dragacevic V, Kalaba P, Urban E, Zehl M, Roller A, Wackerlig J, Langer T, Pistis M, De Luca MA, Caria F, Schwartz R, Presby RE, Yang JH, Samels S, et al. The Novel Atypical Dopamine Uptake Inhibitor -CE-123 Partially Reverses the Effort-Related Effects of the Dopamine Depleting Agent Tetrabenazine and Increases Progressive Ratio Responding. Frontiers in Pharmacology. 10: 682. PMID 31316379 DOI: 10.3389/fphar.2019.00682 |
0.427 |
|
| 2019 |
Congiu M, Trusel M, Pistis M, Mameli M, Lecca S. Opposite responses to aversive stimuli in lateral habenula neurons. The European Journal of Neuroscience. PMID 30860301 DOI: 10.1111/ejn.14400 |
0.462 |
|
| 2018 |
Torres LH, Balestrin NT, Spelta LEW, Duro SO, Pistis M, Marcourakis T. Exposure to tobacco smoke during the early postnatal period modifies receptors and enzymes of the endocannabinoid system in the brainstem and striatum in mice. Toxicology Letters. 302: 35-41. PMID 30553937 DOI: 10.1016/j.toxlet.2018.12.002 |
0.34 |
|
| 2018 |
De Felice M, Melis M, Aroni S, Muntoni AL, Fanni S, Frau R, Devoto P, Pistis M. The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia. Cns Neuroscience & Therapeutics. PMID 30461214 DOI: 10.1111/cns.13087 |
0.739 |
|
| 2018 |
Sagheddu C, Scherma M, Congiu M, Fadda P, Carta G, Banni S, Wood JT, Makriyannis A, Malamas MS, Pistis M. Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward. Neuropharmacology. 144: 327-336. PMID 30439418 DOI: 10.1016/J.Neuropharm.2018.11.013 |
0.476 |
|
| 2018 |
Secci ME, Mascia P, Sagheddu C, Beggiato S, Melis M, Borelli AC, Tomasini MC, Panlilio LV, Schindler CW, Tanda G, Ferré S, Bradberry CW, Ferraro L, Pistis M, Goldberg SR, et al. Astrocytic Mechanisms Involving Kynurenic Acid Control Δ-Tetrahydrocannabinol-Induced Increases in Glutamate Release in Brain Reward-Processing Areas. Molecular Neurobiology. PMID 30151725 DOI: 10.1007/s12035-018-1319-y |
0.628 |
|
| 2017 |
Pistis M, O'Sullivan SE. The Role of Nuclear Hormone Receptors in Cannabinoid Function. Advances in Pharmacology (San Diego, Calif.). 80: 291-328. PMID 28826538 DOI: 10.1016/bs.apha.2017.03.008 |
0.339 |
|
| 2017 |
Puligheddu M, Melis M, Pillolla G, Milioli G, Parrino L, Terzano GM, Aroni S, Sagheddu C, Marrosu F, Pistis M, Muntoni AL. Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy. Epilepsia. PMID 28766701 DOI: 10.1111/epi.13863 |
0.72 |
|
| 2016 |
Scheggi S, Melis M, De Felice M, Aroni S, Muntoni AL, Pelliccia T, Gambarana C, De Montis MG, Pistis M. PPARα modulation of mesolimbic dopamine transmission rescues depression-related behaviors. Neuropharmacology. 110: 251-259. PMID 27457507 DOI: 10.1016/j.neuropharm.2016.07.024 |
0.78 |
|
| 2016 |
Luchicchi A, Lecca S, Melis M, De Felice M, Cadeddu F, Frau R, Muntoni AL, Fadda P, Devoto P, Pistis M. Maternal immune activation disrupts dopamine system in the offspring. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26819283 DOI: 10.1093/Ijnp/Pyw007 |
0.805 |
|
| 2016 |
Scherma M, Muntoni AL, Melis M, Fattore L, Fadda P, Fratta W, Pistis M. Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives. Psychopharmacology. PMID 26728894 DOI: 10.1007/S00213-015-4196-3 |
0.714 |
|
| 2016 |
De Felice M, Aroni S, Muntoni A, Frau R, Fanni S, Pardu A, Devoto P, Pistis M. P.4.010 Effects of maternal immune activation on dopamine activity in male and female offspring European Neuropsychopharmacology. 26: S93-S94. DOI: 10.1016/S0924-977X(16)70100-3 |
0.639 |
|
| 2015 |
Sagheddu C, Muntoni AL, Pistis M, Melis M. Endocannabinoid Signaling in Motivation, Reward, and Addiction: Influences on Mesocorticolimbic Dopamine Function. International Review of Neurobiology. 125: 257-302. PMID 26638769 DOI: 10.1016/bs.irn.2015.10.004 |
0.762 |
|
| 2015 |
Scherma M, Dessì C, Muntoni AL, Lecca S, Satta V, Luchicchi A, Pistis M, Panlilio LV, Fattore L, Goldberg SR, Fratta W, Fadda P. Adolescent Δ(9)-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26388146 DOI: 10.1038/Npp.2015.295 |
0.812 |
|
| 2015 |
Sagheddu C, Aroni S, De Felice M, Lecca S, Luchicchi A, Melis M, Muntoni AL, Romano R, Palazzo E, Guida F, Maione S, Pistis M. Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain. Neuropharmacology. 97: 383-93. PMID 26113399 DOI: 10.1016/J.Neuropharm.2015.06.003 |
0.825 |
|
| 2015 |
Dudok B, Barna L, Ledri M, Szabó SI, Szabadits E, Pintér B, Woodhams SG, Henstridge CM, Balla GY, Nyilas R, Varga C, Lee SH, Matolcsi M, Cervenak J, Kacskovics I, ... ... Pistis M, et al. Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling. Nature Neuroscience. 18: 75-86. PMID 25485758 DOI: 10.1038/Nn.3892 |
0.529 |
|
| 2015 |
Melis M, Colombo G, Pistis M. SY02-3ENDOCANNABINOID-MEDIATED PLASTICITY AT INHIBITORY SYNAPSES ONTO DOPAMINE NEURONS AS A POSSIBLE MARKER OF INNATE PREFERENCE TO ALCOHOL Alcohol and Alcoholism. 50: i3.3-i4. DOI: 10.1093/ALCALC/AGV076.06 |
0.668 |
|
| 2014 |
Melis M, Sagheddu C, De Felice M, Casti A, Madeddu C, Spiga S, Muntoni AL, Mackie K, Marsicano G, Colombo G, Castelli MP, Pistis M. Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in Sardinian alcohol-preferring rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 12716-24. PMID 25232109 DOI: 10.1523/Jneurosci.1844-14.2014 |
0.788 |
|
| 2014 |
Melis M, Pistis M. Targeting the interaction between fatty acid ethanolamides and nicotinic receptors: therapeutic perspectives. Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 86: 42-9. PMID 24704146 DOI: 10.1016/j.phrs.2014.03.009 |
0.573 |
|
| 2013 |
Melis M, De Felice M, Lecca S, Fattore L, Pistis M. Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of Lister Hooded rats. Frontiers in Integrative Neuroscience. 7: 93. PMID 24416004 DOI: 10.3389/Fnint.2013.00093 |
0.665 |
|
| 2013 |
Justinova Z, Mascia P, Wu HQ, Secci ME, Redhi GH, Panlilio LV, Scherma M, Barnes C, Parashos A, Zara T, Fratta W, Solinas M, Pistis M, Bergman J, Kangas BD, et al. Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid. Nature Neuroscience. 16: 1652-61. PMID 24121737 DOI: 10.1038/Nn.3540 |
0.429 |
|
| 2013 |
Puligheddu M, Pillolla G, Melis M, Lecca S, Marrosu F, De Montis MG, Scheggi S, Carta G, Murru E, Aroni S, Muntoni AL, Pistis M. PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings. Plos One. 8: e64541. PMID 23724059 DOI: 10.1371/journal.pone.0064541 |
0.747 |
|
| 2013 |
Melis M, Scheggi S, Carta G, Madeddu C, Lecca S, Luchicchi A, Cadeddu F, Frau R, Fattore L, Fadda P, Ennas MG, Castelli MP, Fratta W, Schilstrom B, Banni S, ... ... Pistis M, et al. PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 6203-11. PMID 23554501 DOI: 10.1523/Jneurosci.4647-12.2013 |
0.833 |
|
| 2013 |
Melis M, Carta G, Pistis M, Banni S. Physiological role of peroxisome proliferator-activated receptors type α on dopamine systems. Cns & Neurological Disorders Drug Targets. 12: 70-7. PMID 23394525 DOI: 10.2174/1871527311312010012 |
0.655 |
|
| 2013 |
Sagheddu C, Melis M, De Felice M, Colombo G, Pistis M. S.07.03 Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction European Neuropsychopharmacology. 23: S120-S121. DOI: 10.1016/S0924-977X(13)70147-0 |
0.509 |
|
| 2013 |
Sagheddu C, Melis M, Pistis M. P.1.024 Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction European Neuropsychopharmacology. 23: S22-S23. DOI: 10.1016/S0924-977X(13)70026-9 |
0.568 |
|
| 2012 |
Melis M, Pistis M. Hub and switches: endocannabinoid signalling in midbrain dopamine neurons. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 367: 3276-85. PMID 23108546 DOI: 10.1098/rstb.2011.0383 |
0.66 |
|
| 2012 |
Barrot M, Sesack SR, Georges F, Pistis M, Hong S, Jhou TC. Braking dopamine systems: a new GABA master structure for mesolimbic and nigrostriatal functions. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 14094-101. PMID 23055478 DOI: 10.1523/Jneurosci.3370-12.2012 |
0.484 |
|
| 2012 |
Luchicchi A, Pistis M. Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids. Molecular Neurobiology. 46: 374-92. PMID 22801993 DOI: 10.1007/S12035-012-8299-0 |
0.696 |
|
| 2012 |
Panlilio LV, Justinova Z, Mascia P, Pistis M, Luchicchi A, Lecca S, Barnes C, Redhi GH, Adair J, Heishman SJ, Yasar S, Aliczki M, Haller J, Goldberg SR. Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1838-47. PMID 22453137 DOI: 10.1038/Npp.2012.31 |
0.745 |
|
| 2012 |
Melis M, Muntoni AL, Pistis M. Endocannabinoids and the processing of value-related signals. Frontiers in Pharmacology. 3: 7. PMID 22347186 DOI: 10.3389/fphar.2012.00007 |
0.794 |
|
| 2012 |
Lecca S, Melis M, Luchicchi A, Muntoni AL, Pistis M. Inhibitory inputs from rostromedial tegmental neurons regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1164-76. PMID 22169942 DOI: 10.1038/Npp.2011.302 |
0.858 |
|
| 2011 |
Lecca S, Melis M, Luchicchi A, Ennas MG, Castelli MP, Muntoni AL, Pistis M. Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 589-602. PMID 21048703 DOI: 10.1038/Npp.2010.190 |
0.855 |
|
| 2011 |
Mascia P, Pistis M, Justinova Z, Panlilio LV, Luchicchi A, Lecca S, Scherma M, Fratta W, Fadda P, Barnes C, Redhi GH, Yasar S, Le Foll B, Tanda G, Piomelli D, et al. Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors. Biological Psychiatry. 69: 633-41. PMID 20801430 DOI: 10.1016/J.Biopsych.2010.07.009 |
0.775 |
|
| 2010 |
Melis M, Carta S, Fattore L, Tolu S, Yasar S, Goldberg SR, Fratta W, Maskos U, Pistis M. Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors. Biological Psychiatry. 68: 256-64. PMID 20570248 DOI: 10.1016/J.Biopsych.2010.04.016 |
0.657 |
|
| 2010 |
Luchicchi A, Lecca S, Carta S, Pillolla G, Muntoni AL, Yasar S, Goldberg SR, Pistis M. Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-alpha nuclear receptors. Addiction Biology. 15: 277-88. PMID 20477753 DOI: 10.1111/J.1369-1600.2010.00222.X |
0.851 |
|
| 2010 |
Fattore L, Melis M, Fadda P, Pistis M, Fratta W. The endocannabinoid system and nondrug rewarding behaviours. Experimental Neurology. 224: 23-36. PMID 20353776 DOI: 10.1016/J.Expneurol.2010.03.020 |
0.545 |
|
| 2010 |
Pistis M, Melis M. From surface to nuclear receptors: the endocannabinoid family extends its assets. Current Medicinal Chemistry. 17: 1450-67. PMID 20166922 DOI: 10.2174/092986710790980014 |
0.512 |
|
| 2010 |
Luchicchi A, Lecca S, Carta S, Pistis M. P.6.d.019 Peroxisome proliferator activated receptors type alpha modulate nicotine effects in the rat ventral tegmental area European Neuropsychopharmacology. 20: S598-S599. DOI: 10.1016/S0924-977X(10)70913-5 |
0.729 |
|
| 2010 |
Lecca S, Luchicchi A, Carta S, Melis M, Muntoni A, Pistis M. P.6.d.018 Cocaine, morphine and the cannabinoid win55212 depress neuronal activity in the rostromedial tegmental nucleus European Neuropsychopharmacology. 20: S598. DOI: 10.1016/S0924-977X(10)70912-3 |
0.778 |
|
| 2009 |
Melis M, Pillolla G, Perra S, Colombo G, Muntoni AL, Pistis M. Electrophysiological properties of dopamine neurons in the ventral tegmental area of Sardinian alcohol-preferring rats. Psychopharmacology. 201: 471-81. PMID 18777018 DOI: 10.1007/s00213-008-1309-2 |
0.83 |
|
| 2009 |
Luchicchi A, Lecca S, Carta S, Pillolla G, Pistis M. P6.d.009 Inhibition of anandamide hydrolysis differentially modulates cocaine-induced effects on rat mesolimbic system European Neuropsychopharmacology. 19: S662-S663. DOI: 10.1016/S0924-977X(09)71068-5 |
0.722 |
|
| 2009 |
Luchicchi A, Pillolla G, Lecca S, Pistis M. P.4.08 Inhibition of anandamide hydrolysis antagonizes nicotine effects on neurons in the nucleus accumbens shell in the rat European Neuropsychopharmacology. 19: S86-S86. DOI: 10.1016/S0924-977X(09)70098-7 |
0.779 |
|
| 2008 |
Melis M, Pillolla G, Luchicchi A, Muntoni AL, Yasar S, Goldberg SR, Pistis M. Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 13985-94. PMID 19091987 DOI: 10.1523/Jneurosci.3221-08.2008 |
0.838 |
|
| 2008 |
Fattore L, Fadda P, Spano MS, Pistis M, Fratta W. Neurobiological mechanisms of cannabinoid addiction. Molecular and Cellular Endocrinology. 286: S97-S107. PMID 18372102 DOI: 10.1016/J.Mce.2008.02.006 |
0.4 |
|
| 2008 |
Perra S, Pillolla G, Luchicchi A, Pistis M. Alcohol inhibits spontaneous activity of basolateral amygdala projection neurons in the rat: involvement of the endocannabinoid system. Alcoholism, Clinical and Experimental Research. 32: 443-9. PMID 18215217 DOI: 10.1111/J.1530-0277.2007.00588.X |
0.811 |
|
| 2007 |
Melis M, Pistis M. Endocannabinoid signaling in midbrain dopamine neurons: more than physiology? Current Neuropharmacology. 5: 268-77. PMID 19305743 DOI: 10.2174/157015907782793612 |
0.668 |
|
| 2007 |
Castelli MP, Paola Piras A, D'Agostino A, Pibiri F, Perra S, Gessa GL, Maccarrone M, Pistis M. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2. European Journal of Pharmacology. 573: 11-9. PMID 17644084 DOI: 10.1016/j.ejphar.2007.06.047 |
0.803 |
|
| 2007 |
Pillolla G, Melis M, Perra S, Muntoni AL, Gessa GL, Pistis M. Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo. Psychopharmacology. 191: 843-53. PMID 17334799 DOI: 10.1007/s00213-007-0733-z |
0.848 |
|
| 2007 |
Pillolla G, Perra S, Melis M, Muntoni A, Pistis M. P.1.20 Medial forebrain bundle stimulation induces changes in dopamine neuron activity: role of endocannabinoids and glutamate European Neuropsychopharmacology. 17: S18. DOI: 10.1016/S0924-977X(07)70021-4 |
0.835 |
|
| 2006 |
Melis M, Pillolla G, Bisogno T, Minassi A, Petrosino S, Perra S, Muntoni AL, Lutz B, Gessa GL, Marsicano G, Di Marzo V, Pistis M. Protective activation of the endocannabinoid system during ischemia in dopamine neurons. Neurobiology of Disease. 24: 15-27. PMID 16762556 DOI: 10.1016/J.Nbd.2006.04.010 |
0.84 |
|
| 2006 |
Muntoni AL, Pillolla G, Melis M, Perra S, Gessa GL, Pistis M. Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons. The European Journal of Neuroscience. 23: 2385-94. PMID 16706846 DOI: 10.1111/j.1460-9568.2006.04759.x |
0.833 |
|
| 2006 |
Pistis M, Perra S, Pillolla G, Muntoni A, Melis M. P.6.b.001 The endocannabinoid system in the effects of alcohol on limbic neurons:an in vivo electrophysiological study European Neuropsychopharmacology. 16: S496-S497. DOI: 10.1016/S0924-977X(06)70672-1 |
0.8 |
|
| 2005 |
Perra S, Pillolla G, Melis M, Muntoni AL, Gessa GL, Pistis M. Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo. Psychopharmacology. 183: 368-77. PMID 16228194 DOI: 10.1007/s00213-005-0195-0 |
0.829 |
|
| 2005 |
Pistis M, Muntoni AL, Pillolla G, Perra S, Cignarella G, Melis M, Gessa GL. Gamma-hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit: evidence for GABA(B) receptor-mediated effects. Neuroscience. 131: 465-74. PMID 15708487 DOI: 10.1016/j.neuroscience.2004.11.021 |
0.829 |
|
| 2004 |
Melis M, Perra S, Muntoni AL, Pillolla G, Lutz B, Marsicano G, Di Marzo V, Gessa GL, Pistis M. Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 10707-15. PMID 15564588 DOI: 10.1523/Jneurosci.3502-04.2004 |
0.842 |
|
| 2004 |
Pistis M, Perra S, Pillolla G, Melis M, Muntoni AL, Gessa GL. Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons. Biological Psychiatry. 56: 86-94. PMID 15231440 DOI: 10.1016/j.biopsych.2004.05.006 |
0.843 |
|
| 2004 |
Melis M, Pistis M, Perra S, Muntoni AL, Pillolla G, Gessa GL. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 53-62. PMID 14715937 DOI: 10.1523/JNEUROSCI.4503-03.2004 |
0.829 |
|
| 2004 |
Pistis M, Perra S, Pillolla G, Melis M, Gessa GL, Muntoni AL. Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions. Neuropharmacology. 46: 115-25. PMID 14654103 DOI: 10.1016/j.neuropharm.2003.08.003 |
0.843 |
|
| 2003 |
Sanna A, Congeddu E, Porcella A, Saba L, Pistis M, Peis M, Marchese G, Ruiu S, Lobina C, Grayson DR, Gessa GL, Pani L. Characterization of wild-type (R100R) and mutated (Q100Q) GABAA alpha 6 subunit in Sardinian alcohol non-preferring rats (sNP). Brain Research. 967: 98-105. PMID 12650970 DOI: 10.1016/S0006-8993(02)04230-0 |
0.609 |
|
| 2002 |
Pistis M, Ferraro L, Pira L, Flore G, Tanganelli S, Gessa GL, Devoto P. Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study. Brain Research. 948: 155-8. PMID 12383968 DOI: 10.1016/S0006-8993(02)03055-X |
0.679 |
|
| 2002 |
Castelli MP, Mocci I, Pistis M, Peis M, Berta D, Gelain A, Gessa GL, Cignarella G. Stereoselectivity of NCS-382 binding to gamma-hydroxybutyrate receptor in the rat brain. European Journal of Pharmacology. 446: 1-5. PMID 12098579 DOI: 10.1016/S0014-2999(02)01713-2 |
0.588 |
|
| 2002 |
Pistis M, Muntoni AL, Pillolla G, Gessa GL. Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study. The European Journal of Neuroscience. 15: 1795-802. PMID 12081659 DOI: 10.1046/j.1460-9568.2002.02019.x |
0.817 |
|
| 2001 |
Pistis M, Porcu G, Melis M, Diana M, Gessa GL. Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation. The European Journal of Neuroscience. 14: 96-102. PMID 11488953 DOI: 10.1046/j.0953-816X.2001.01612.x |
0.836 |
|
| 2001 |
Saba L, Porcella A, Congeddu E, Colombo G, Peis M, Pistis M, Gessa GL, Pani L. The R100Q mutation of the GABA(A) alpha(6) receptor subunit may contribute to voluntary aversion to ethanol in the sNP rat line. Brain Research. Molecular Brain Research. 87: 263-70. PMID 11245930 DOI: 10.1016/S0169-328X(01)00003-1 |
0.598 |
|
| 2000 |
Gessa GL, Devoto P, Diana M, Flore G, Melis M, Pistis M. Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 642-9. PMID 10788763 DOI: 10.1016/S0893-133X(00)00087-7 |
0.839 |
|
| 1999 |
Belelli D, Pistis M, Peters JA, Lambert JJ. General anaesthetic action at transmitter-gated inhibitory amino acid receptors. Trends in Pharmacological Sciences. 20: 496-502. PMID 10603492 DOI: 10.1016/S0165-6147(99)01405-4 |
0.311 |
|
| 1999 |
Diana M, Muntoni AL, Pistis M, Melis M, Gessa GL. Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal. The European Journal of Neuroscience. 11: 1037-41. PMID 10103095 DOI: 10.1046/j.1460-9568.1999.00488.x |
0.838 |
|
| 1999 |
Davies PA, Pistis M, Hanna MC, Peters JA, Lambert JJ, Hales TG, Kirkness EF. The 5-HT3B subunit is a major determinant of serotonin-receptor function. Nature. 397: 359-63. PMID 9950429 DOI: 10.1038/16941 |
0.307 |
|
| 1999 |
Pistis M, Belelli D, McGurk K, Peters JA, Lambert JJ. Complementary regulation of anaesthetic activation of human (alpha6beta3gamma2L) and Drosophila (RDL) GABA receptors by a single amino acid residue. The Journal of Physiology. 515: 3-18. PMID 9925873 DOI: 10.1111/J.1469-7793.1999.003Ad.X |
0.305 |
|
| 1997 |
Pistis M, Belelli D, Peters JA, Lambert JJ. The interaction of general anaesthetics with recombinant GABAA and glycine receptors expressed in Xenopus laevis oocytes: a comparative study. British Journal of Pharmacology. 122: 1707-19. PMID 9422818 DOI: 10.1038/Sj.Bjp.0701563 |
0.3 |
|
| 1997 |
Pistis M, Muntoni AL, Gessa G, Diana M. Effects of acute, chronic ethanol and withdrawal on dorsal raphe neurons: electrophysiological studies. Neuroscience. 79: 171-6. PMID 9178873 DOI: 10.1016/S0306-4522(96)00643-4 |
0.827 |
|
| 1996 |
Diana M, Pistis M, Muntoni A, Gessa G. Mesolimbic dopaminergic reduction outlasts ethanol withdrawal syndrome: evidence of protracted abstinence. Neuroscience. 71: 411-5. PMID 9053796 DOI: 10.1016/0306-4522(95)00482-3 |
0.819 |
|
| 1996 |
Diana M, Muntoni AL, Pistis M, Collu M, Forgione A, Gessa GL. Chronic administration of l-sulpiride at low doses reduces A10 but not A9 somatodentritic dopamine autoreceptor sensitivity. European Journal of Pharmacology. 312: 179-81. PMID 8894593 DOI: 10.1016/0014-2999(96)00581-X |
0.803 |
|
| 1995 |
Diana M, Pistis M, Muntoni A, Gessa G. Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats. The Journal of Pharmacology and Experimental Therapeutics. 272: 781-5. PMID 7853194 |
0.83 |
|
| 1995 |
Devoto P, Collu M, Muntoni AL, Pistis M, Serra G, Gessa GL, Diana M. Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system. Synapse (New York, N.Y.). 20: 153-5. PMID 7570345 DOI: 10.1002/syn.890200209 |
0.825 |
|
| 1995 |
Diana M, Pistis M, Muntoni AL, Gessa GL. Ethanol withdrawal does not induce a reduction in the number of spontaneously active dopaminergic neurons in the mesolimbic system. Brain Research. 682: 29-34. PMID 7552323 DOI: 10.1016/0006-8993(95)00292-X |
0.844 |
|
| 1995 |
Pistis M, Diana M, Muntoni AL, Maccioni F, Gessa GL. Reduction of mesolimbic dopaminergic activity outlasts ethanol withdrawal syndrome in rats Behavioural Pharmacology. 6: 90. DOI: 10.1097/00008877-199505001-00104 |
0.665 |
|
| 1995 |
Pistis M, Diana M, Muntoni AL, Palomba F, Gessa GL. Decrease of serotoninergic neuronal activity during ethanol withdrawal syndrome in rats Behavioural Pharmacology. 6: 89. DOI: 10.1097/00008877-199505001-00103 |
0.703 |
|
| 1995 |
Muntoni AL, Diana M, Pistis M, Maccioni F, Gessa GL. Long lasting reduction of mesolimbic dopaminergic neuronal activity after morphine withdrawal Behavioural Pharmacology. 6: 85. DOI: 10.1097/00008877-199505001-00100 |
0.719 |
|
| 1995 |
Diana M, Pistis M, Muntoni AL, Gessa GL. No reduction of spontaneously active mesolimbic dopaminergic neurons in ethanol withdrawn rats Behavioural Pharmacology. 6: 80. DOI: 10.1097/00008877-199505001-00094 |
0.73 |
|
| 1995 |
Devoto P, Collu M, Muntoni AL, Pistis M, Serra G, Gessa GL, Diana M. Effects of 7-OH-DPAT on the rat mesolimbic dopaminergic system Behavioural Pharmacology. 6: 71. DOI: 10.1097/00008877-199505001-00085 |
0.752 |
|
| 1995 |
Diana M, Pistis M, Muntoni AL, Collu M, Forgione A, Gossa GL. Plasticity changes in dopamine autoreceptor function after chronic L-sulpiride Behavioural Pharmacology. 6: 19. DOI: 10.1097/00008877-199505001-00020 |
0.768 |
|
| 1993 |
Diana M, Pistis M, Muntoni A, Gessa G. Heterogeneous responses of substantia nigra pars reticulata neurons to gamma-hydroxybutyric acid administration. European Journal of Pharmacology. 230: 363-5. PMID 8440312 DOI: 10.1016/0014-2999(93)90574-2 |
0.839 |
|
| 1993 |
Diana M, Pistis M, Carboni S, Gessa GL, Rossetti ZL. Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence. Proceedings of the National Academy of Sciences of the United States of America. 90: 7966-9. PMID 8367449 DOI: 10.1073/Pnas.90.17.7966 |
0.776 |
|
| 1992 |
Diana M, Pistis M, Muntoni A, Rossetti ZL, Gessa G. Marked decrease of A10 dopamine neuronal firing during ethanol withdrawal syndrome in rats. European Journal of Pharmacology. 221: 403-4. PMID 1426019 DOI: 10.1016/0014-2999(92)90734-L |
0.814 |
|
| 1992 |
Diana M, Pistis M, Muntoni A, Gessa GL. Electrophysiological effects of acute and chronic ethanol administration Pharmacological Research. 26: 216. DOI: 10.1016/1043-6618(92)91142-4 |
0.747 |
|
| Show low-probability matches. |